Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Myeloid malignancies-related somatic mutations in aging individuals.

Coutinho DF, Zalcberg IR, Monte-Mór BCR.

Mol Genet Genomic Med. 2019 Jun;7(6):e683. doi: 10.1002/mgg3.683. Epub 2019 Apr 21.

2.

Characterization of a human induced Pluripotent Stem (iPS) cell line (INCABRi002-A) derived from a primary myelofibrosis patient harboring the 5-bp insertion in CALR and the p.W146X mutation in TP53.

Gomez Limia CE, Devalle S, Reis M, Sochacki J, Madeiro da Costa R, D'Andrea M, Padilha T, Zalcberg IR, Solza C, Daumas A, Rehen S, Bonamino MH, Monte-Mór B.

Stem Cell Res. 2018 Dec;33:130-134. doi: 10.1016/j.scr.2018.09.012. Epub 2018 Sep 20.

3.

Genetic Alterations in Essential Thrombocythemia Progression to Acute Myeloid Leukemia: A Case Series and Review of the Literature.

Ayres-Silva JP, Bonamino MH, Gouveia ME, Monte-Mor BCR, Coutinho DF, Daumas AH, Solza C, Braggio E, Zalcberg IR.

Front Oncol. 2018 Feb 19;8:32. doi: 10.3389/fonc.2018.00032. eCollection 2018.

4.

Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52bp deletion and the ASXL1 p.R693X mutation.

Gomez Limia CE, Devalle S, Reis M, Sochacki J, Carneiro M, Madeiro da Costa R, D'Andrea M, Padilha T, Zalcberg IR, Solza C, Daumas A, Rehen S, Monte-Mór B, Bonamino MH.

Stem Cell Res. 2017 Oct;24:16-20. doi: 10.1016/j.scr.2017.08.006. Epub 2017 Aug 8.

5.

Familial Myelodysplastic/Acute Leukemia Syndromes-Myeloid Neoplasms with Germline Predisposition.

Baptista RLR, Dos Santos ACE, Gutiyama LM, Solza C, Zalcberg IR.

Front Oncol. 2017 Sep 12;7:206. doi: 10.3389/fonc.2017.00206. eCollection 2017. Review.

6.

Identification of the MYST3-CREBBP fusion gene in infants with acute myeloid leukemia and hemophagocytosis.

Andrade FG, Noronha EP, Baseggio RM, Fonseca TC, Freire BM, Quezado Magalhaes IM, Zalcberg IR, Pombo-de-Oliveira MS.

Rev Bras Hematol Hemoter. 2016 Oct - Dec;38(4):291-297. doi: 10.1016/j.bjhh.2016.06.005. Epub 2016 Jul 26.

7.

Genetic aberrations in multiple myeloma characterized by cIg-FISH: a Brazilian context.

Segges P, Braggio E, Minnicelli C, Hassan R, Zalcberg IR, Maiolino A.

Braz J Med Biol Res. 2016;49(5):e5034. doi: 10.1590/1414-431X20155034. Epub 2016 Apr 8.

8.

An unusual long-term outcome of a child with primary myelofibrosis harboring a JAK2 mutation.

Maia RC, Bonamino MH, Robaina MC, Amaral N, Bonecker S, Zalcberg IR, Klumb CE.

Blood Cells Mol Dis. 2015 Dec;55(4):347-50. doi: 10.1016/j.bcmd.2015.07.013. Epub 2015 Jul 21.

PMID:
26460258
9.

TET2 expression level and 5-hydroxymethylcytosine are decreased in refractory cytopenia of childhood.

Coutinho DF, Monte-Mór BC, Vianna DT, Rouxinol ST, Batalha AB, Bueno AP, Boulhosa AM, Fernandez TS, Pombo-de-Oliveira MS, Gutiyama LM, Abdelhay E, Zalcberg IR.

Leuk Res. 2015 Oct;39(10):1103-8. doi: 10.1016/j.leukres.2015.07.005. Epub 2015 Jul 14.

PMID:
26277372
10.

Case report: A novel TET2 mutation in a patient with refractory cytopenia with multilineage dysplasia.

Coutinho DF, Diniz C, Filgueiras RL, Baptista RL, Ayres-Silva JP, Monte-Mór BC, Bonamino MH, Zalcberg IR.

Genet Mol Res. 2013 Nov 22;12(4):5858-62. doi: 10.4238/2013.November.22.13.

11.

Myeloid neoplasias: what molecular analyses are telling us.

Gutiyama LM, Coutinho DF, Lipkin MV, Zalcberg IR.

ISRN Oncol. 2012;2012:321246. doi: 10.5402/2012/321246. Epub 2012 Sep 27.

12.

Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma.

Minnicelli C, Barros MH, Klumb CE, Romano SO, Zalcberg IR, Hassan R.

PLoS One. 2012;7(9):e46005. doi: 10.1371/journal.pone.0046005. Epub 2012 Sep 27.

13.

miRNA-451: A putative predictor marker of Imatinib therapy response in chronic myeloid leukemia.

Scholl V, Hassan R, Zalcberg IR.

Leuk Res. 2012 Jan;36(1):119-21. doi: 10.1016/j.leukres.2011.08.023. Epub 2011 Sep 25. No abstract available.

PMID:
21944890
14.

Hydroxyurea dose impacts hematologic parameters in polycythemia vera and essential thrombocythemia but does not appreciably affect JAK2-V617F allele burden.

Zalcberg IR, Ayres-Silva J, de Azevedo AM, Solza C, Daumas A, Bonamino M.

Haematologica. 2011 Mar;96(3):e18-20. doi: 10.3324/haematol.2010.037846. No abstract available.

15.

JAK2V617F mutation in patients with thrombosis: to screen or not to screen?

Xavier SG, Gadelha T, Rezende SM, Zalcberg IR, Spector N.

Int J Lab Hematol. 2011 Apr;33(2):117-24. doi: 10.1111/j.1751-553X.2010.01275.x. Epub 2010 Dec 1. Review.

PMID:
21118380
16.

Cell cycle characteristics and Epstein-Barr virus are differentially associated with aggressive and non-aggressive subsets of Hodgkin lymphoma in pediatric patients.

Barros MH, Scheliga A, De Matteo E, Minnicelli C, Soares FA, Zalcberg IR, Hassan R.

Leuk Lymphoma. 2010 Aug;51(8):1513-22. doi: 10.3109/10428194.2010.489243.

PMID:
20687799
17.

JAK2V617F mutation in patients with splanchnic vein thrombosis.

Xavier SG, Gadelha T, Pimenta G, Eugenio AM, Ribeiro DD, Gomes FM, Bonamino M, Zalcberg IR, Spector N.

Dig Dis Sci. 2010 Jun;55(6):1770-7. doi: 10.1007/s10620-009-0933-y. Epub 2009 Aug 19.

PMID:
19690956
18.

EBV-associated post transplant lymphoproliferative disorder of the 'loser' graft cell origin following double unrelated umbilical cord blood transplantation.

Hassan R, Stefanoff CG, Maradei S, Fernandes GA, Barros MH, Carestiato FN, Romano SO, Bouzas LF, Zalcberg IR.

Bone Marrow Transplant. 2009 Aug;44(3):193-5. doi: 10.1038/bmt.2008.445. Epub 2009 Feb 9. No abstract available.

PMID:
19204712
19.

Second Epstein-Barr virus-associated Burkitt's lymphoma of the CNS in a child with progressive renal failure.

Hassan R, Stefanoff CG, Felisbino F, Barros MH, Zalcberg IR, Klumb CE, Bigni RS, Seuánez HN.

J Clin Oncol. 2008 Jun 20;26(18):3085-7. doi: 10.1200/JCO.2007.15.1431. No abstract available.

PMID:
18565896
20.

Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt's lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region.

Hassan R, Klumb CE, Felisbino FE, Guiretti DM, White LR, Stefanoff CG, Barros MH, Seuánez HN, Zalcberg IR.

Haematologica. 2008 May;93(5):780-3. doi: 10.3324/haematol.12424. Epub 2008 Mar 26.

21.

Prognostic impact of CD15 expression and proliferative index in the outcome of children with classical Hodgkin lymphoma.

Barros MH, Zalcberg IR, Hassan R.

Pediatr Blood Cancer. 2008 Feb;50(2):428-9; author reply 430. No abstract available.

PMID:
17973313
22.

Clinical and laboratorial prediction of bone marrow involvement in children and adolescents with Hodgkin Lymphoma.

Barros MH, Zalcberg IR, Hassan R.

Pediatr Blood Cancer. 2008 Apr;50(4):765-8.

PMID:
17763463
23.

A recurrent splicing variant without c-ABL Exon 7 in Imatinib-resistant patients.

Curvo RP, Zalcberg IR, Scholl V, Pires V, Moellmann-Coelho A, Moreira MA.

Leuk Res. 2008 Mar;32(3):508-10. Epub 2007 Jun 13. No abstract available.

PMID:
17570524
24.

Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections.

Hassan R, Franco SA, Stefanoff CG, Romano SO, Diamond HR, Franco LG, Seuánez HN, Zalcberg IR.

Pathol Int. 2006 Nov;56(11):668-73.

PMID:
17040289
25.

Epstein-Barr virus (EBV) detection and typing by PCR: a contribution to diagnostic screening of EBV-positive Burkitt's lymphoma.

Hassan R, White LR, Stefanoff CG, de Oliveira DE, Felisbino FE, Klumb CE, Bacchi CE, Seuánez HN, Zalcberg IR.

Diagn Pathol. 2006 Aug 7;1:17.

27.

p53 protein expression does not correlate with EBV status in childhood B non-Hodgkin lymphomas.

Klumb CE, Hassan R, Zalcberg IR, Resende LM, Carriço MK, Maia RC.

Pediatr Blood Cancer. 2004 Aug;43(2):115-9.

PMID:
15236276
28.

Granulocytic sarcoma of the small intestine with CBFbeta/MYH11 fusion gene: report of an aleukaemic case and review of the literature.

Xavier SG, Fagundes EM, Hassan R, Bacchi C, Conchon M, Tabak DG, Spector N, Zalcberg IR.

Leuk Res. 2003 Nov;27(11):1063-6. Review.

PMID:
12859999
29.

Laboratory strategies for efficient handling of paraffin-embedded tissues for molecular detection of clonality in non-hodgkin lymphomas.

Stefanoff CG, Hassan R, Gonzalez AC, Andrade LA, Tabak DG, Romano S, Zalcberg IR.

Diagn Mol Pathol. 2003 Jun;12(2):79-87.

PMID:
12766612
30.

Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21.

Willis TG, Zalcberg IR, Coignet LJ, Wlodarska I, Stul M, Jadayel DM, Bastard C, Treleaven JG, Catovsky D, Silva ML, Dyer MJ.

Blood. 1998 Mar 15;91(6):1873-81.

PMID:
9490669

Supplemental Content

Loading ...
Support Center